Drug resistance is a major biomedical challenge that undermines treatments for infectious diseases, cancer, and viral infections worldwide. Classical computational models fail to capture the full molecular complexity underlying these processes due to inherent approximations and computational constraints. Quantum models offer a computationally advanced framework, enabling more accurate simulation of molecular interactions and improved understanding of drug-target binding and resistance mechanisms. Image Credit: Saiful52/Shutterstock.com Why Is It Difficult to Model Drug Resistance? Drug resistance represents an adaptive biological response in which cells, pathogens, or organisms lose sensitivity to therapeutic agents that were previously effective, driven by evolutionary selection that favors survival of resistant variants under drug pressure. At the molecular level, this resistance arises through multiple mechanisms, including enzymatic drug inactivation, reduced intracellular accumulation via decreased uptake or active efflux, and structural modification of drug targets that lowers binding affinity while preserving biological function. Additional pathways include target overproduction, metabolic bypass mechanisms that circumvent inhibited steps, and target mimicry that sequesters drugs away from their intended binding sites. These mechanisms frequently act in combination, producing robust and multifactorial resistance phenotypes that reduce therapeutic efficacy and complicate long-term disease management across infectious diseases, oncology, and other biological systems.1,2 Limitations in Modeling Modeling drug resistance presents significant challenges due to the dynamic, heterogeneous, and multiscale nature of biological systems, combined with fundamental limitations of classical computational approaches. Biological populations evolve continuously under therapeutic pressure, while rare mutations in a small subset of cells can rapidly dominate a population. This dynamic adaptive behavior introduces significant stochasticity, making resistance trajectories difficult to predict using deterministic models alone. Limitations in experimental data, particularly the absence of real-time, patient-specific measurements, further reduce model reliability, making drug resistance modeling a problem that requires integrating evolutionary biology, multiscale modeling, and quantum-level accuracy.3,4 What Can Quantum Models do Against